• Je něco špatně v tomto záznamu ?

Arterial Stiffness and Cardiometabolic-Based Chronic Disease: The Kardiovize Study

I. Pavlovska, JI. Mechanick, GA. Maranhao Neto, MM. Infante-Garcia, R. Nieto-Martinez, S. Kunzova, A. Polcrova, R. Vysoky, JR. Medina-Inojosa, F. Lopez-Jimenez, GB. Stokin, JP. González-Rivas

. 2021 ; 27 (6) : 571-578. [pub] 20210313

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21018502

OBJECTIVE: Arterial stiffness (ArSt) describes a loss of arterial wall elasticity and is an independent predictor of cardiovascular events. A cardiometabolic-based chronic disease model integrates concepts of adiposity-based chronic disease (ABCD), dysglycemia-based chronic disease (DBCD), and cardiovascular disease. We assessed if ABCD and DBCD models detect more people with high ArSt compared with traditional adiposity and dysglycemia classifiers using the cardio-ankle vascular index (CAVI). METHODS: We evaluated 2070 subjects aged 25 to 64 years from a random population-based sample. Those with type 1 diabetes were excluded. ABCD and DBCD were defined, and ArSt risk was stratified based on the American Association of Clinical Endocrinologists criteria. RESULTS: The highest prevalence of a high CAVI was in stage 2 ABCD (18.5%) and stage 4 DBCD (31.8%), and the lowest prevalence was in stage 0 ABCD (2.2%). In univariate analysis, stage 2 ABCD and all DBCD stages increased the risk of having a high CAVI compared with traditional classifiers. After adjusting for age and gender, only an inverse association between obesity (body mass index ≥30 kg/m2) and CAVI remained significant. Nevertheless, body mass index was responsible for only 0.3% of CAVI variability. CONCLUSION: The ABCD and DBCD models showed better performance than traditional classifiers to detect subjects with ArSt; however, the variables were not independently associated with age and gender, which might be explained by the complexity and multifactoriality of the relationship of CAVI with the ABCD and DBCD models, mediated by insulin resistance.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21018502
003      
CZ-PrNML
005      
20241203101822.0
007      
ta
008      
210728s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.eprac.2021.03.004 $2 doi
035    __
$a (PubMed)33722731
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Pavlovska, Iuliia $u International Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), Czech Republic; Department of Public Health, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Electronic address: iuliia.pavlovska@fnusa.cz
245    10
$a Arterial Stiffness and Cardiometabolic-Based Chronic Disease: The Kardiovize Study / $c I. Pavlovska, JI. Mechanick, GA. Maranhao Neto, MM. Infante-Garcia, R. Nieto-Martinez, S. Kunzova, A. Polcrova, R. Vysoky, JR. Medina-Inojosa, F. Lopez-Jimenez, GB. Stokin, JP. González-Rivas
520    9_
$a OBJECTIVE: Arterial stiffness (ArSt) describes a loss of arterial wall elasticity and is an independent predictor of cardiovascular events. A cardiometabolic-based chronic disease model integrates concepts of adiposity-based chronic disease (ABCD), dysglycemia-based chronic disease (DBCD), and cardiovascular disease. We assessed if ABCD and DBCD models detect more people with high ArSt compared with traditional adiposity and dysglycemia classifiers using the cardio-ankle vascular index (CAVI). METHODS: We evaluated 2070 subjects aged 25 to 64 years from a random population-based sample. Those with type 1 diabetes were excluded. ABCD and DBCD were defined, and ArSt risk was stratified based on the American Association of Clinical Endocrinologists criteria. RESULTS: The highest prevalence of a high CAVI was in stage 2 ABCD (18.5%) and stage 4 DBCD (31.8%), and the lowest prevalence was in stage 0 ABCD (2.2%). In univariate analysis, stage 2 ABCD and all DBCD stages increased the risk of having a high CAVI compared with traditional classifiers. After adjusting for age and gender, only an inverse association between obesity (body mass index ≥30 kg/m2) and CAVI remained significant. Nevertheless, body mass index was responsible for only 0.3% of CAVI variability. CONCLUSION: The ABCD and DBCD models showed better performance than traditional classifiers to detect subjects with ArSt; however, the variables were not independently associated with age and gender, which might be explained by the complexity and multifactoriality of the relationship of CAVI with the ABCD and DBCD models, mediated by insulin resistance.
650    _2
$a tlakový index kotník-paže $7 D055109
650    _2
$a index tělesné hmotnosti $7 D015992
650    12
$a kardiovaskulární nemoci $x epidemiologie $7 D002318
650    _2
$a chronická nemoc $7 D002908
650    _2
$a endokrinologové $7 D000072097
650    _2
$a lidé $7 D006801
650    _2
$a rizikové faktory $7 D012307
650    12
$a tuhost cévní stěny $7 D059289
655    _2
$a časopisecké články $7 D016428
700    1_
$a Mechanick, Jeffrey I $u The Marie-Josée and Henry R. Kravis Center for Cardiovascular Health at Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York; Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, New York
700    1_
$a Maranhao Neto, Geraldo A $u International Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), Czech Republic
700    1_
$a Infante-Garcia, Maria M $u Foundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN INC), Caracas, Venezuela
700    1_
$a Nieto-Martinez, Ramfis $u Foundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN INC), Caracas, Venezuela; Department of Global Health and Population, Harvard TH Chan School of Public Health, Harvard University, Boston, Massachusetts; LifeDoc Health, Memphis, Tennessee
700    1_
$a Kunzova, Sarka $u International Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), Czech Republic
700    1_
$a Bartošková, Anna $u International Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), Czech Republic; Research Centre for Toxic Compounds in the Environment (RECETOX), Masaryk University, Brno, Czech Republic $7 mub20241225433
700    1_
$a Vysoky, Robert $u Department of Public Health, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Faculty of Sport Studies - Department of Health Support, Masaryk University, Brno, Czech Republic
700    1_
$a Medina-Inojosa, Jose R $u Division of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, Minnesota
700    1_
$a Lopez-Jimenez, Francisco $u Division of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, Minnesota
700    1_
$a Stokin, Gorazd B $u International Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), Czech Republic
700    1_
$a González-Rivas, Juan P $u International Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), Czech Republic; Foundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN INC), Caracas, Venezuela; Department of Global Health and Population, Harvard TH Chan School of Public Health, Harvard University, Boston, Massachusetts
773    0_
$w MED00207059 $t Endocrine practice $x 1530-891X $g Roč. 27, č. 6 (2021), s. 571-578
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33722731 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20241203101818 $b ABA008
999    __
$a ok $b bmc $g 1689564 $s 1138948
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 27 $c 6 $d 571-578 $e 20210313 $i 1530-891X $m Endocrine practice $n Endocr Pract $x MED00207059
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...